Top Markets
Coin of the day
Carbiotix AB Carbiotix AB

Carbiotix AB

CRBX
Rank in Stocks #35613
Carbiotix AB is a therapeutics company currently in the pre-clinical... Carbiotix AB is a therapeutics company currently in the pre-clinical development stage. It specializes in creating products and medicines intended to stimulate beneficial bacteria in the gut, with the aim of addressing metabolic and chronic illnesses. The company was established in 2014 and is headquartered in Lund, Sweden.
Share Price
$0.73494346
Last synced: 2025-12-15
Market Cap
$3.66M
Change (1 day)
18.28%
Change (1 year)
-29.75%
Country
SE
Trade Carbiotix AB (CRBX)

Category

P/E ratio for Carbiotix AB (CRBX)
P/E ratio as of 2026 TTM: 0
According to Carbiotix AB latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Carbiotix AB from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
40.14 -
US
- -
CA
19.51 -
US
20.38 -
AU
42.73 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.